AC Immune SA, a Swiss-based biotech, announced that it has received fast-track designation from the U.S. Food and Drug Administration (FDA) for its ...

UBS analyst Eliana Merle has upgraded shares of biotech company Moderna to Buy from Neutral, attributing the move to investors’ lack of appreciation ...